Report overview
Diet therapy is the traditional method of inborn errors of metabolism. Medical food is the specialized food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. Inborn errors of metabolism refer to inherited disorders due to mutation in genes coding for proteins functioning in metabolism. The inborn errors of metabolism are a heterogeneous group of disorders and are likely to be inherited through spontaneous mutation. The diseases usually involve failure of metabolic pathways that are either involved in breakdown or storage of biomolecules, such as carbohydrates, proteins, and fatty acids.
This report aims to provide a comprehensive presentation of the global market for Medical Foods for Inborn Errors of Metabolism, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Foods for Inborn Errors of Metabolism. This report contains market size and forecasts of Medical Foods for Inborn Errors of Metabolism in global, including the following market information:
Global Medical Foods for Inborn Errors of Metabolism Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global Medical Foods for Inborn Errors of Metabolism Market Sales, 2018-2023, 2024-2035, (K Units)
Global top five Medical Foods for Inborn Errors of Metabolism companies in 2022 (%)
The global Medical Foods for Inborn Errors of Metabolism market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Amino Acid Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Medical Foods for Inborn Errors of Metabolism include Nestl?, Abbott, Reckitt Benckiser Group, Ajinomoto, Solace Nutrition, Primus Pharmaceuticals, BioMarin Pharmaceutical, Danone SA and Galen Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Medical Foods for Inborn Errors of Metabolism manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Foods for Inborn Errors of Metabolism Market, by Type, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Medical Foods for Inborn Errors of Metabolism Market Segment Percentages, by Type, 2022 (%)
Amino Acid
Glytactin with GMP
Amino Acid-Modified Infant Formula With Iron
Low Protein Food
Others
Global Medical Foods for Inborn Errors of Metabolism Market, by Application, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Medical Foods for Inborn Errors of Metabolism Market Segment Percentages, by Application, 2022 (%)
Phenylketonuria (PKU)
Maple Syrup Urine Disease (MSUD)
Urea Cycle Disorders
Renal Disease
Others
Global Medical Foods for Inborn Errors of Metabolism Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Medical Foods for Inborn Errors of Metabolism Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Foods for Inborn Errors of Metabolism revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Medical Foods for Inborn Errors of Metabolism revenues share in global market, 2022 (%)
Key companies Medical Foods for Inborn Errors of Metabolism sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Medical Foods for Inborn Errors of Metabolism sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nestl?
Abbott
Reckitt Benckiser Group
Ajinomoto
Solace Nutrition
Primus Pharmaceuticals
BioMarin Pharmaceutical
Danone SA
Galen Limited
PKU-MDMIL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medical Foods for Inborn Errors of Metabolism, market overview.
Chapter 2: Global Medical Foods for Inborn Errors of Metabolism market size in revenue and volume.
Chapter 3: Detailed analysis of Medical Foods for Inborn Errors of Metabolism manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Foods for Inborn Errors of Metabolism in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medical Foods for Inborn Errors of Metabolism capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
